Which drug classes, when abused, can lead to hepatic injury?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medication Categories That Lead to Liver Damage When Abused

Acetaminophen (paracetamol) is the most critical medication to recognize, as it is the leading cause of acute liver failure in the United States and Europe, with doses exceeding 10 grams per day commonly causing hepatotoxicity, though injury can occur at doses as low as 3-4 grams per day. 1

Primary Hepatotoxic Drug Classes

Analgesics

  • Acetaminophen/Paracetamol: Dose-dependent hepatotoxin causing the full spectrum from transaminase elevation to fulminant hepatic failure and death. Repeated supratherapeutic ingestions (>4g/day) can result in severe hepatotoxicity, with mortality rates of 14% in patients presenting with severe hepatotoxicity (AST >1,000 IU/L) 2
  • Very high aminotransferases (>3,500 IU/L) are highly correlated with acetaminophen poisoning 1

Antibiotics

  • Most frequently implicated drug class in drug-induced liver injury (DILI) 3, 4
  • Amoxicillin-clavulanate and trimethoprim-sulfamethoxazole: Leading causes in Western countries 3
  • Cefazolin: Newly recognized phenotype causing prominent cholestatic or mixed reaction 2-3 weeks after ultra-short exposure (1-2 doses) 4
  • Ornidazole: Associated with hepatocellular jaundice requiring liver transplantation in 8% of affected patients 4
  • Nitrofurantoin and minocycline: Can cause drug-induced autoimmune-like hepatitis 5

Psychotropic Medications

  • Chlorpromazine: Prototype drug causing prolonged cholestasis (>6 months) and vanishing bile duct syndrome leading to permanent liver damage 6
  • Methyldopa and hydralazine: Associated with drug-induced autoimmune-like hepatitis 5

Cardiovascular Drugs

  • Statins (particularly atorvastatin): Can cause autoimmune-like hepatitis with spontaneous relapse in 7 of 24 cases after steroid withdrawal 5

Anti-TNF Agents

  • Infliximab and adalimumab: Cause drug-induced autoimmune-like hepatitis, with 20-33% improving on drug withdrawal alone, but up to 14% requiring liver transplantation 5

Herbal and Dietary Supplements (HDS)

Increasingly implicated worldwide with worsening outcomes for HDS-related acute liver failure 3:

  • Ashwagandha
  • Turmeric/green tea extract
  • Polygonum multiflorum
  • Tinospora cordifolia
  • Garcinia cambogia
  • Kratom

These can cause the full spectrum from asymptomatic enzyme elevation to acute liver failure requiring transplantation 3, 4

Immunomodulatory Agents

  • Checkpoint inhibitors: Most frequent cause of DILI in recent Barcelona study, typically presenting within first 6 months with asymptomatic laboratory abnormalities 3, 4
  • Kinase inhibitors: Newer recognized cause for cancer and autoimmune conditions 3

Substances of Abuse

Alcohol

  • Prototype hepatotoxin causing the complete spectrum: simple steatosis, steatohepatitis, alcoholic hepatitis, and cirrhosis 7, 8

Cocaine

  • Causes ischemic hepatonecrosis in acute overdose and clinically inapparent transaminasemia 7, 8

Amphetamine-Type Stimulants

  • Induce hepatotoxicity through reactive metabolite formation, reactive oxygen species generation, and mitochondrial damage 9, 8

Critical Clinical Pitfalls

Do not assume chronic alcohol use increases acetaminophen hepatotoxicity risk at therapeutic doses - Class I evidence found no support for this commonly held belief 2

Patient-reported dosing regimens are unreliable and may be clinically misleading 2

Drug-induced autoimmune-like hepatitis (DI-AILH) differs from idiopathic autoimmune hepatitis: it rarely relapses after steroid withdrawal, is associated with only mild fibrosis, and rarely progresses to cirrhosis 5

Outcome Considerations

Over 80% of DILI patients fully recover within 6 months of drug discontinuation with supportive care, but patients with underlying chronic liver disease have increased morbidity and mortality when DILI occurs 10, 3. Recent outcomes for HDS-related acute liver failure have been worsening 3.

The primary treatment remains immediate withdrawal of the offending agent with close monitoring 6, 1, 6. Corticosteroids show benefit only in highly selected patients 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.